TI
GANX icon

Telemetry Investments’s Gain Therapeutics GANX Stock Holding History

Telemetry Investments’s Portfolio GANX Stock Details GANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$385K Sell
123,000
-27,000
-18% -$84.4K 0.9% 44
2022
Q3 		$489K Sell
150,000
-10,000
-6% -$37.6K 0.8% 49
2022
Q2 		$576K Sell
160,000
-80,000
-33% -$276K 0.88% 43
2022
Q1 		$979K Buy
240,000
+88,868
+59% +$372K 1.57% 14
2021
Q4 		$807K Buy
151,132
+54,900
+57% +$379K 1.06% 23
2021
Q3 		$716K Buy
96,232
+65,939
+218% +$551K 0.98% 38
2021
Q2 		$303K Buy
+30,293
New +$342K 0.42% 76

Other funds holding GANX

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.3B AUM 62.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
WAAG
Wealth Alliance Advisory Group Wichita, Kansas $632M AUM 18.54% 1-Year Est. Return